GHANA CYCLOTRON FACILITY CONSTRUCTION
The SGMC Cyclotron Center in Ghana marks a groundbreaking initiative, being the first of its kind in the country. Spanning two floors, this state-of-the-art facility houses a cyclotron unit and cleanroom labs on the ground floor, while the first floor accommodates a nuclear medicine department. Notably, the same medicine produced by the cyclotron is used for patient treatment in the nuclear medicine department, with the potential for global distribution, significantly impacting healthcare on a worldwide scale. Covering a total construction area of 1730 square meters, with a base area of 615 square meters, this center stands as a beacon of advanced medical technology. Situated in an essential and isolated site in Ghana, supported by the Swedish government, it serves as a pivotal hub for cancer care in West Africa and beyond, adhering meticulously to European and international standards, including those set by the IAEA, drawing visits from their authorities. Named the "SGMC Cyclotron Center," this project has seen collaboration with industry giants like IBA and Siemens for construction and device supply, showcasing a convergence of expertise and technology to revolutionize cancer care and medical advancements in the region and beyond. SGMC, as the primary employer, has partnered closely with Radmed to accomplish this astonishing project, underscoring their dedication to advancing healthcare in the region. The project showcases a commitment to sustainability by harnessing the abundant solar energy available in Ghana. Additionally, for the long-term sustainability of the building in this difficult geography, all materials used, especially in terms of plumbing and mechanical infrastructure, were designed and applied using extra durable materials, considering future use and possible maintenance scenarios. Beyond technological achievements, the Cyclotron Center holds promise for socio-economic development. It is expected to generate numerous job opportunities locally, becoming a cornerstone not only in Ghana but throughout Africa in the battle against cancer. Radmed's primary focus on patient-oriented care remains steadfast, aiming to evolve SGMC's established approach within this innovative project, thereby promising an even greater impact on patient well-being. Radmed's primary focus on patient-oriented services remains steadfast, aiming to evolve SGMC's established approach within this innovative project, thereby promising an even greater impact on patient well-being.